Pancreatic Cancer Research

ResearcherAdvantagene (United States)No recent work listed

Laura K. Aguilar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3473-0330; OpenAlex author ID A5051302499. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper

Papers 2

  1. Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma. Co-author DOI 10.1007/s00262-015-1679-3↗
  2. Therapeutic endoscopic ultrasonography: intratumoral injection for pancreatic adenocarcinoma. First author DOI 10.1155/2013/207129↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lawrence A. Shirley · 2 shared papers, 2013–2015 · strength 0.09
  2. Jon P. Walker · 2 shared papers, 2013–2015 · strength 0.09
  3. Mark Bloomston · 2 shared papers, 2013–2015 · strength 0.09
  4. Vincent M. Chung · 1 shared paper, 2015 · strength 0.04
  5. Tanios Bekaii‐Saab · 1 shared paper, 2015 · strength 0.04
  6. Gregory B. Lesinski · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.